Immunocore Holdings plc (IMCR) Misses Q1 EPS by 14c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q1 EPS of ($0.43), $0.14 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $55.09 million versus the consensus estimate of $40.37 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c